Vaccine Delivery Devices Global Market Report 2024

The vaccine delivery devices market size has grown rapidly in recent years. It will grow from $5.81 billion in 2023 to $6.39 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the adoption of disposable syringes, large-scale polio vaccination campaigns, initiatives including the global alliance for vaccines and immunization (GAVI), smallpox eradication efforts, and the vaccine alliance.

The vaccine delivery devices market size is expected to see rapid growth in the next few years. It will grow to $9.45 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%. The anticipated growth in the forecast period is driven by several factors, including increased attention on immunization initiatives, the expansion of vaccine development projects, the growing numbers of pediatric and geriatric demographics, the prioritization of cold chain management, and heightened awareness regarding preventive healthcare practices. Key trends expected during this period encompass ongoing advancements in vaccine delivery device technology, a shift towards needle-free solutions, progress in personalized medicine approaches, the introduction of new self-administered vaccines, and the formation of strategic partnerships.

The rise in infectious diseases prevalence is poised to drive the expansion of the vaccine delivery devices market. Infectious diseases, caused by various microorganisms such as bacteria, viruses, fungi, or parasites, spread through various means including person-to-person contact, animals, vectors, or contaminated substances. Factors contributing to the prevalence of infectious diseases include increased global travel, rapid urbanization, shifts in climate patterns, and population expansion. Vaccine delivery devices play a pivotal role in disease prevention by effectively administering vaccines to populations, bolstering immunity, and curbing transmission rates. For instance, as reported by the World Health Organization (WHO) in November 2023, approximately 10.6 million cases of tuberculosis (TB) were reported worldwide in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Consequently, the pervasive presence of infectious diseases underpins the growth of the vaccine delivery devices market.

Major companies in the vaccine delivery devices sector are innovating by introducing products such as prefillable syringes to improve the effectiveness and safety of vaccine delivery. Prefillable syringes are designed to securely contain and dispense a predetermined dosage of medication, typically in liquid form, specifically for vaccines. For example, in September 2022, Becton, Dickinson, and Company (BD), a US-based medical technology firm, launched the BD Effivax Glass Prefillable Syringe. This advanced vaccine delivery device aims to address the evolving requirements of vaccine production by enhancing reliability and efficiency in vaccine administration. The syringe incorporates enhanced technology and stricter specifications to provide increased fill or finish reliability and container durability, thereby reducing the risk of production interruptions and enhancing manufacturing capabilities.

In January 2022, ICU Medical Inc., a US-based producer of cutting-edge medical equipment utilized in infusion therapy, purchased Smiths Medical from Smiths Group plc for an undisclosed sum. This acquisition was aimed at integrating syringe and ambulatory infusion devices, vascular access tools, and essential care products into ICU Medical's range. Smiths Medical, a US-based company, specializes in vaccine delivery devices.

Major companies operating in the vaccine delivery devices market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis International AG, AstraZeneca PLC, 3M Company, GlaxoSmithKline plc, Moderna Inc., Becton Dickinson and Company (BD), Sinovac Biotech Co. Ltd., CSL Limited, INOVIO Pharmaceuticals Inc., Terumo Corporation, SCHOTT AG, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Dynavax Technologies Corporation, CanSino Biologics Inc., Vaxxas Inc., PharmaJet Inc., Enesi Pharma Limited, NanoPass Technologies Ltd., Gerresheimer AG, Panacea Biotec Limited.

North America was the largest region in the vaccine delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vaccine delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Vaccine delivery devices are mechanisms or systems devised to safely and efficiently administer vaccines to individuals. Engineered with precision, these tools guarantee precise dosage, accurate delivery, and minimal discomfort for the recipient. Their significance in public health endeavors lies in their ability to facilitate the distribution and application of vaccines, thereby thwarting the spread of infectious diseases.

The primary categories of vaccine delivery devices comprise needle-free injection systems, oral delivery systems, nasal delivery systems, jet injectors, microneedle patches, and microinjectors. Needle-free injection systems are medical tools designed to administer medication into the skin without employing a conventional needle. They facilitate various routes of administration, including intradermal, intramuscular, and subcutaneous vaccination, and are utilized by a range of end-users, including hospitals and clinics.

The vaccine delivery devices market research report is one of a series of new reports that provides vaccine delivery devices market statistics, including the vaccine delivery devices industry global market size, regional shares, competitors with vaccine delivery devices market share, detailed vaccine delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the vaccine delivery devices industry. These vaccine delivery devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vaccine delivery devices market consists of sales of jet injectors, auto-injectors, oral vaccine delivery, microneedle patches, transdermal patches, inhalers, and intradermal devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.